Igor S Lukashevich

Summary

Affiliation: University of Louisville
Country: USA

Publications

  1. pmc An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
    Juan C Zapata
    Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA
    Virol J 10:52. 2013
  2. pmc The search for animal models for Lassa fever vaccine development
    Igor S Lukashevich
    Department of Pharmacology and Toxicology, School of Medicine and the Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, KY 40202, USA
    Expert Rev Vaccines 12:71-86. 2013
  3. pmc Advanced vaccine candidates for Lassa fever
    Igor S Lukashevich
    Department of Pharmacology and Toxicology, School of Medicine, and Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Kentucky, USA
    Viruses 4:2514-57. 2012

Collaborators

  • Juan C Zapata
  • Joseph Bryant
  • Dmitry Moshkoff
  • Harry Davis
  • Bhawna Poonia
  • Eugene Ateh
  • C David Pauza
  • Yan Zhang
  • Lanea George
  • Maria S Salvato
  • Crystal Jaing
  • Tom Slezak
  • Oswald Crasta
  • Marco Goicochea

Detail Information

Publications3

  1. pmc An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
    Juan C Zapata
    Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA
    Virol J 10:52. 2013
    ..However, since the LHF endemic area of West Africa also has high HIV seroprevalence, it is important to determine whether vaccination could be safe in the context of HIV infection...
  2. pmc The search for animal models for Lassa fever vaccine development
    Igor S Lukashevich
    Department of Pharmacology and Toxicology, School of Medicine and the Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Louisville, KY 40202, USA
    Expert Rev Vaccines 12:71-86. 2013
    ..All of these challenges will be addressed in this review in the context of available and novel animal models recently described for evaluation of LF vaccine candidates...
  3. pmc Advanced vaccine candidates for Lassa fever
    Igor S Lukashevich
    Department of Pharmacology and Toxicology, School of Medicine, and Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, Kentucky, USA
    Viruses 4:2514-57. 2012
    ..The current status of pre-clinical development of the advanced vaccine candidates that have been tested in non-human primates will be discussed. Major scientific, manufacturing, and regulatory challenges will also be considered...